[go: up one dir, main page]

IL128931A0 - Tricylic antitumor compounds being farnesyl protein transferase inhibitors - Google Patents

Tricylic antitumor compounds being farnesyl protein transferase inhibitors

Info

Publication number
IL128931A0
IL128931A0 IL12893197A IL12893197A IL128931A0 IL 128931 A0 IL128931 A0 IL 128931A0 IL 12893197 A IL12893197 A IL 12893197A IL 12893197 A IL12893197 A IL 12893197A IL 128931 A0 IL128931 A0 IL 128931A0
Authority
IL
Israel
Prior art keywords
tricylic
protein transferase
transferase inhibitors
farnesyl protein
antitumor compounds
Prior art date
Application number
IL12893197A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of IL128931A0 publication Critical patent/IL128931A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL12893197A 1996-09-13 1997-09-11 Tricylic antitumor compounds being farnesyl protein transferase inhibitors IL128931A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US71298996A 1996-09-13 1996-09-13
US87740097A 1997-06-17 1997-06-17
PCT/US1997/015899 WO1998011092A1 (fr) 1996-09-13 1997-09-11 Composes antitumoraux tricycliques inhibiteurs de la farnesyl transferase proteique

Publications (1)

Publication Number Publication Date
IL128931A0 true IL128931A0 (en) 2000-02-17

Family

ID=27108923

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12893197A IL128931A0 (en) 1996-09-13 1997-09-11 Tricylic antitumor compounds being farnesyl protein transferase inhibitors

Country Status (12)

Country Link
EP (1) EP0929544B1 (fr)
JP (1) JP2001521489A (fr)
KR (1) KR20000036111A (fr)
CN (1) CN1238770A (fr)
AT (1) ATE282036T1 (fr)
AU (1) AU4801197A (fr)
CA (1) CA2266015C (fr)
DE (1) DE69731544T2 (fr)
ES (1) ES2229340T3 (fr)
HU (1) HUP0001109A2 (fr)
IL (1) IL128931A0 (fr)
WO (1) WO1998011092A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ501612A (en) * 1997-06-17 2001-11-30 Schering Corp Benzo[5,6]cyclohepta[1,2-b]pyridine derivatives useful for inhibition of farnesyl protein transferase
US6211193B1 (en) 1997-06-17 2001-04-03 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US6218401B1 (en) 1997-06-17 2001-04-17 Schering Corporation Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase
CN1286690A (zh) * 1997-06-17 2001-03-07 先灵公司 用于抑制法尼基蛋白转移酶的化合物
US5925639A (en) * 1997-06-17 1999-07-20 Schering Corporation Keto amide derivatives useful as farnesyl protein transferase inhibitors
US6228865B1 (en) 1997-06-17 2001-05-08 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US5852034A (en) * 1997-06-17 1998-12-22 Schering Corporation Benzo(5,6)cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors
ATE309249T1 (de) 1998-01-21 2005-11-15 Millennium Pharm Inc Chemokin rezeptor antagonisten und verwndung
US6613905B1 (en) 1998-01-21 2003-09-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
AU2335699A (en) 1998-01-21 1999-08-09 Kyowa Hakko Kogyo Co. Ltd. Chemokine receptor antagonists and methods of use therefor
US6509346B2 (en) 1998-01-21 2003-01-21 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
ATE274498T1 (de) * 1998-07-24 2004-09-15 Russinsky Ltd Verfahren zur herstellung von benzocycloheptapyridin-11-one
US6503926B2 (en) 1998-09-04 2003-01-07 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6288083B1 (en) 1998-09-04 2001-09-11 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US7271176B2 (en) 1998-09-04 2007-09-18 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use thereof
US6262216B1 (en) 1998-10-13 2001-07-17 Affymetrix, Inc. Functionalized silicon compounds and methods for their synthesis and use
US6638950B2 (en) 2000-06-21 2003-10-28 Bristol-Myers Squibb Pharma Company Piperidine amides as modulators of chemokine receptor activity
US7342016B2 (en) 2000-08-30 2008-03-11 Schering Corporation Farnesyl protein transferase inhibitors as antitumor agents
US7541365B2 (en) 2001-11-21 2009-06-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
AR041466A1 (es) * 2002-10-03 2005-05-18 Schering Corp Proceso enantioselectivo para preparar compuestos triciclicos quirales
TWI291467B (en) 2002-11-13 2007-12-21 Millennium Pharm Inc CCR1 antagonists and methods of use therefor
JP4614770B2 (ja) * 2002-11-18 2011-01-19 シェーリング コーポレイション アンドロゲン依存性疾患を処置するための１７β−ヒドロキシステロイドデヒドロゲナーゼタイプ３インヒビター
EP1656156A2 (fr) 2003-08-13 2006-05-17 Children's Hospital Medical Center Mobilisation de cellules hematopoietques
US7820673B2 (en) * 2003-12-17 2010-10-26 Takeda Pharmaceutical Company Limited Urea derivative, process for producing the same, and use
JP2007529555A (ja) * 2004-03-18 2007-10-25 ザ ブライハム アンド ウイメンズ ホスピタル， インコーポレイテッド シヌクレイノパチーを治療する方法
CN113549072B (zh) * 2020-04-23 2024-12-06 鲁南制药集团股份有限公司 一种托法替布杂质ⅰ的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089496A (en) * 1986-10-31 1992-02-18 Schering Corporation Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
US4826853A (en) * 1986-10-31 1989-05-02 Schering Corporation 6,11-Dihydro-11-(N-substituted-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines and compositions and methods of use
KR920014799A (ko) * 1991-01-18 1992-08-25 나오가따 다이도 신규벤조[5,6]시클로헵타[1,2-b]피리딘 유도체 및 이를 함유하는 항알레르기제
DK0723538T3 (da) * 1993-10-15 2002-03-18 Schering Corp Tricykliske carbamatforbindelser, der er nyttige til inhibition af funktion af G-protein og til behandling af proliferative sygdomme
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them
US5721236A (en) * 1993-10-15 1998-02-24 Schering Corporation Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5719148A (en) * 1993-10-15 1998-02-17 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
US5700806A (en) * 1995-03-24 1997-12-23 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
IL117798A (en) * 1995-04-07 2001-11-25 Schering Plough Corp Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them
US5712280A (en) * 1995-04-07 1998-01-27 Schering Corporation Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
CA2240846C (fr) * 1995-12-22 2002-07-16 Schering Corporation Amides tricycliques destines a l'inhibition de la fonction de la proteine-g et au traitement des maladies proliferatives

Also Published As

Publication number Publication date
CA2266015A1 (fr) 1998-03-19
AU4801197A (en) 1998-04-02
DE69731544D1 (de) 2004-12-16
EP0929544B1 (fr) 2004-11-10
WO1998011092A1 (fr) 1998-03-19
ATE282036T1 (de) 2004-11-15
JP2001521489A (ja) 2001-11-06
CA2266015C (fr) 2003-12-30
KR20000036111A (ko) 2000-06-26
DE69731544T2 (de) 2005-10-27
EP0929544A1 (fr) 1999-07-21
HK1018446A1 (en) 1999-12-24
HUP0001109A2 (hu) 2001-04-28
ES2229340T3 (es) 2005-04-16
CN1238770A (zh) 1999-12-15

Similar Documents

Publication Publication Date Title
IL128931A0 (en) Tricylic antitumor compounds being farnesyl protein transferase inhibitors
IL128928A0 (en) Tricyclic inhibitors of farnesyl protein transferase
MY114792A (en) Farnesyl transferase inhibitors,their preparation and pharmaceutical compositions comprising them
IL125785A0 (en) Farnesyl transferase inhibitors
IL127574A0 (en) Inhibitors of prenyl transferases
PL332240A1 (en) Tricyclic compounds useful in inhibiting g-proteinic function and in treating proliferative diseases
IL128951A0 (en) Tricyclic compounds useful for inhibition of farnesyl protein transferase
IL128929A0 (en) Substituted benzocycloheptapyridine derivatives useful for inhibition of farnesyl protein transferase
MY117925A (en) Compounds for the inhibition of farnesyl protein transferase.
MX9801792A (es) Inhibidores cicloantihelminticos.
IL128930A0 (en) Compounds useful for inhibition of farnesyl protein transferase
IL133447A0 (en) Compounds useful for inhibition of farnesyl protein transferase
IL128927A0 (en) Substituted benzocycloheptapyridine derivatives useful for inhibition of farnesyl protein transferase